Long-Term Assets: The sum of all assets classified as non-current.
Quantum Biopharma Ltd. (QNTM) had Long-Term Assets of $4.56M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-13.56M |
|
-- |
|
-- |
|
$2.97M |
|
$-2.97M |
|
$-10.79M |
|
$-13.75M |
|
$-13.52M |
|
$-13.75M |
|
$-13.75M |
|
$-13.75M |
|
$-13.52M |
|
$-2.97M |
|
$-2.84M |
|
4.49M |
|
4.49M |
|
$-3.06 |
|
$-3.06 |
|
| Balance Sheet Financials | |
$10.37M |
|
$0.06M |
|
|
Long-Term Assets |
$4.56M |
$14.93M |
|
$16.35M |
|
-- |
|
-- |
|
$16.35M |
|
$-1.42M |
|
$-5.83M |
|
$-1.42M |
|
5.86M |
|
| Cash Flow Statement Financials | |
$-1.67M |
|
$-2.89M |
|
$7.00M |
|
$1.91M |
|
$4.34M |
|
$2.44M |
|
$0.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.63 |
|
-- |
|
-- |
|
-- |
|
-0.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.67M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
968.64% |
|
235.94% |
|
-92.14% |
|
968.63% |
|
$-0.24 |
|
$-0.37 |
|
$-0.37 |
|